Health knowledge made personal
Join this community!
› Share page:
Search posts:

A Good Day for Lipitor

Posted Oct 28 2008 9:57pm
It’s a good day for Lipitor. And a good day for Pfizer.

This morning, Pfizer announced that the U.S. FDA had granted Lipitor (atorvastatin) five new indications, including, “reduce the risk of nonfatal heart attacks, fatal and non-fatal strokes, certain types of heart surgery, hospitalization for heart failure, and chest pain in patients with heart disease.”

This comes on the heels of a retrospective analysis using a managed care database showing a 14% reduction in the risk of cardiovascular events with Lipitor compared to simvastatin. This is real-world clinical outcomes.

The winds of change might be blowing, but it’s still not smooth sailing on East 42nd Street yet.
Post a comment
Write a comment:

Related Searches